Dr. Joni A. Tilford
Claim this profileCancer Partners of Nebraska - Pine Lake
Studies Cancer
Studies Lung Cancer
21 reported clinical trials
49 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Joni A. Tilford is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Joni A. Tilford
Clinical Trial Related4 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Joni A. Tilford has experience with
- Paclitaxel
- Durvalumab
- Trastuzumab
- Pertuzumab
- Nivolumab
- Ipilimumab
Breakdown of trials Joni A. Tilford has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joni A. Tilford specialize in?
Joni A. Tilford focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Joni A. Tilford currently recruiting for clinical trials?
Yes, Joni A. Tilford is currently recruiting for 13 clinical trials in Lincoln Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Joni A. Tilford has studied deeply?
Yes, Joni A. Tilford has studied treatments such as Paclitaxel, Durvalumab, Trastuzumab.
What is the best way to schedule an appointment with Joni A. Tilford?
Apply for one of the trials that Joni A. Tilford is conducting.
What is the office address of Joni A. Tilford?
The office of Joni A. Tilford is located at: Cancer Partners of Nebraska - Pine Lake, Lincoln, Nebraska 68516 United States. This is the address for their practice at the Cancer Partners of Nebraska - Pine Lake.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.